RE: Updated..........13 Sep 2022 12:44
Apollon Formularies plc (AQSE: APOL), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, announces that it has been notified on 13th of September 2022, that Roderick ("Rod") Claude McIllree, Non-Executive Director, has transferred 10,000,000 Ordinary Shares for nil consideration to Stene Jacobs, Chief Operating Officer, on 13th of September 2022.
Following the transfer, Rod McIllree is interested in 207,485,940 Ordinary Shares representing approximately 26.9% of the issued share capital of the Company.
Following the transfer, Stene Jacobs is interested in 11,382,306 Ordinary Shares representing approximately 1.48% of the issued share capital of the Company.
https://www.investegate.co.uk/apollon-formularies--apol-/rns/directors--dealing/202209130700121849Z/